Macrolide Pharmaceuticals focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens. Using novel technology, Macrolide Pharmaceuticals can synthesize a broad range of macrolides, and initial compounds show promising anti-bacterial activity.
Market
Antibiotics for bacterial infections
Location
Watertown,
MA,
USA
Coinvestors
Gurnet Point Capital, Novartis Venture Funds, Roche Venture Fund, SR One